Showing 511-520 of 2687 results for "".
Congenital Myasthenic Syndrome Treatment
https://practicalneurology.com/diseases-diagnoses/neuromuscular/congenital-myasthenic-syndrome-treatment/31555/Heterogeneity makes diagnosis and treatment challenging.Dementia Insights: Primary Prevention of Dementia
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/dementia-insights-primary-prevention-of-dementia/31722/Evidence for modifiable lifestyle factors for dementia prevention is growing.Movement Disorders Moment: Incorporating Lifestyle Medicine Into Parkinson Disease Care—Evidence and Guidance for Clinical Practice
https://practicalneurology.com/diseases-diagnoses/movement-disorders/movement-disorders-moment-incorporating-lifestyle-medicine-into-parkinson-disease-care-evidence-and-guidance-for-clinical-practice/32196/Lifestyle medicine strategies play an important role in managing Parkinson disease and empowering patients and their care partners.Update in Epilepsy Therapeutics
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/update-in-epilepsy-therapeutics/30511/In addition to comorbid conditions and side effects, cost and availability should factor into therapeutic selection.In the Pipeline
https://practicalneurology.com/columns/practice-management/in-the-pipeline/30821/Opportunities for Patients Arising From Practicalities of Health Care
https://practicalneurology.com/archives/2018-feb/opportunities-for-patients-arising-from-practicalities-of-health-care/30273/Telepresence in Neurology
https://practicalneurology.com/columns/practice-management/telepresence-in-neurology/30389/Multiple Sclerosis: In-Focus
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-in-focus/30519/Delayed MS Drugs Awaits Decision at FDA
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/delayed-ms-drugs-awaits-decision-at-fda/30657/Pain and Gain: Reassessing Hydrocodone Prescribing
https://practicalneurology.com/diseases-diagnoses/headache-pain/pain-and-gain-reassessing-hydrocodone-prescribing/30742/New recommendations by an FDA committee aim to decrease opioid abuse, the group says, but will physicians and patients bear the burden of its effects?